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Abstract
A study was performed to examine the administration of flunixin meglumine
(FM; an inhibitor of prostaglandin F2α) following artificial insemination on pregnancy
rates of lactating dairy cattle. Jersey and Holstein cows (n=106) were randomly assigned
to receive intravenously either FM (2.2 mg/kg BW) or saline (SAL; 1 mL/23 kg BW).
Cows were randomly allotted to treatment by lactation number, bovine somatotropin
administration, breed, BW, days in milk, milk production, and 305 ME milk production.
Study was performed from September through April and all cows were milked twice
daily.

Following estrous synchronization (cloprostenol, 500 µg im), cows were

artificially inseminated 12 ± 6 h after the onset of estrus was detected utilizing electronic
monitoring. Administration of FM or SAL was administered 5 d ± 12 h following
artificial insemination. Animals underwent verification of pregnancy 28-35 d following
artificial insemination using transrectal ultrasonography by an individual blinded to
treatment. Pregnancy was determined by the presence or absence of an embryo with a
heartbeat.

Pregnancy data were analyzed using CRD Mixed ANOVA Analysis.

Administration of FM following artificial insemination did not improve pregnancy rates
in lactating dairy cows (FM, 37 vs SAL, 31.4%; P > 0.10). In conclusion, treatment with
flunixin meglumine did not improve pregnancy rates when administered following
artificial insemination in lactating dairy cows.
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1. Introduction
Reproductive failure in dairy cows is a problem that has increased over the last
three decades and continues to plague the modern dairy producer (reviewed by Lucy,
2001). When dairy cattle suffer reproductive difficulties, they encounter increased days
open, a term that refers to the time during which an animal is not pregnant (reviewed by
Lucy, 2001). An increase in days open can result in a loss of income. The average dairy
cow costs the producer up to $4.00 per each day open after 85 days postpartum (Britt,
1975). In order to avoid this monetary loss, the producer must reestablish pregnancy
approximately 60-90 days postpartum. However, many factors, such as an animal’s
stress level and nutrition, can lead to the failure of reestablishing and maintaining
pregnancy during this time period.
Lactating dairy cows endure continuous stress due to two - and, in some cases,
three - milkings every day. Heat stress due to ambient temperature is another factor that
tends to hinder pregnancy (reviewed by De Rensis and Scaramuzzi, 2003). Management
practices that use stimulating growth hormones (Cole et al., 1991; reviewed by Dohoo et
al., 2003) and highly concentrated nutrition can negatively affect days open in dairy cows
(O’Callaghan et al., 2000). Since failure to establish and maintain pregnancy in an
animal results in monetary loss for the agricultural industry, researchers must determine
other means by which reproduction can be made more successful. One course of action
is to control the prostaglandins produced during establishment of pregnancy.
Prostaglandins are hormones that are released by most mammalian cells (Bito,
1975). They are involved in inflammation, pain and fever production, control of blood
vessel tone, luteolysis, and blood clotting (Nett et al., 1976; Seibert et al., 1994; Blatteis
1

and Sehic, 1997). The study of luteolysis is central to understanding how to maintain
pregnancy. Prostaglandin F2alpha (PGF2α) is capable of lysing the corpus luteum (CL) on
the mammalian ovary (reviewed by Bazer et al., 1993). The CL is responsible for the
production of progesterone, the hormone that maintains pregnancy (Fields, 1991).
Prostaglandin F2α not only lyses the corpus luteum, but it also provides a dangerous
environment for the embryo. Studies indicate the presence of high concentrations of
PGF2α around the embryo at days 5-8 of development have a negative effect on continued
development (Schrick et al., 1993; Breuel et al., 1993; Seals et al., 1998; Lemaster et al.,
1999; Hockett et al, 2004; Scenna et al., 2004a).
Research has explored effects of PGF2α on the embryo at early stages of
development. Studies have been performed in which PGF2α was administered on days 5
through 8 following artificial insemination.

These studies involved cows that were

supplemented with progestogen, and the results indicated a reduction in pregnancy rates
and the development of retarded embryos (Buford et al., 1996; Hockett et al., 2004; Seals
et al., 1998; Lemaster et al., 1999). These results indicate a direct and/or indirect effect
of PGF2α on embryonic survival in the cow.

Schrick and coworkers (1993) reported a

negative correlation between embryo quality and high uterine luminal concentrations of
PGF2α. Breuel and coworkers (1993) reported detrimental effects on 8-cell rat embryos
when cultured with PGF2α. The culture of these 8-cell embryos with PGF2α caused a
decrease in the number of embryos reaching morula, blastocyst, and expanded blastocyst
stages (Breuel et al., 1993).
The failure for an embryo to advance to morula and blastocyst stages results in
embryonic death. Data presented by Breuel (1993) agree with the indications made by
2

Schrick (1993) that increased concentrations of PGF2α in the uterine lumen may
contribute to embryonic mortality.

Scenna and coworkers (2004a) reported that PGF2α

had a negative effect on the continued development of both in vitro and in vivo-derived
embryos. Reduced blastocyst formation was seen in 16-32 cell stage embryos that were
in vitro derived. A reduction in blastocyst formation was not seen in in vivo-derived
embryos, but a reduction in hatching blastocysts was observed. Extensive studies have
indicated that PGF2α does in fact have an effect on embryo quality and survival;
therefore, these studies indicate that PGF2α may be causing early embryonic mortality.
Premature release of uterine luminal concentrations of PGF2α can be the result of several
factors such as heat stress (Putney et al.,1989; Maylayer et al., 1990), nutrition (reviewed
by Butler, 1998), mastitis (Hockett et al., 2000), and manipulation of the reproductive
tract during artificial insemination and embryo transfer (Wann and Randel, 1990; Velez
et al., 1991; Scenna et al., 2004b).
Artificial insemination is a management tool utilized by the majority of cattle
producers in animal agriculture. It is a process that allows an individual to maximize the
genetic potential of an animal by choosing from several hundred sires. Studies have
shown that manipulation of the reproductive tract during artificial insemination or
embryonic transfer causes an increase in PGF2α concentrations (Wann and Randel, 1990;
Scenna et al., 2004b).

Manipulation of the reproductive tract, and insertion of the

artificial insemination gun into the cow’s reproductive tract, results in an inflammatory
response. Flunixin meglumine is a known inhibitor of certain enzymes involved in
inflammatory responses (Odensvik et al., 1989). The inhibition of these enzymes causes
a block of 15-ketodihydro-PGF2α, the main metabolite of PGF2α (Odensvik et al., 1995;
3

Konigsson et al., 2003). Administration of flunixin meglumine at the time of embryo
transfer has been shown to increase pregnancy rates in cows (Scenna et al., 2004b). The
act of transferring an embryo in a cow involves all actions involved in artificial
insemination. The administration of flunixin meglumine following artificial insemination,
and its effects on pregnancy rates, will be addressed by this thesis.
The specific objective of the continued work in this field is to discover more
efficient means of establishing and maintaining pregnancy in dairy and beef cattle;
therefore, lowering the cost of production. The specific aim of this study is to increase
reproductive performance by decreasing embryonic mortality through the use of
prostaglandin inhibitors.

It is hypothesized that administration of a prostaglandin

inhibitor will improve reproductive efficiency in lactating dairy cattle due to the stress of
high milk production and factors associated with high milk production. This task will be
attempted by administering flunixin meglumine at day 5 following artificial insemination.
A decrease in embryonic mortality will increase pregnancy rates, thus allowing for a
better reproductive efficiency. A higher reproductive efficiency will decrease the number
of days open of an individual animal, and save the average dairy producer approximately
$60,000 per year. The savings of the average producer calculates into millions of dollars
for animal agriculture in the nation. A lower production cost allows for a better and more
consistent product for the public.

4

2. Literature Review
2.1 Reproductive Inefficiency in Dairy Cattle
The dairy industry has changed dramatically in the past decades. Milk production
per cow has increased as a result of better management, nutrition, and genetic selection.
Dairy farms in the United States have grown into larger operations. Nearly 30% of the
cows in the United States are on farms with 500 cows or more (reviewed by Lucy, 2001).
A shift towards more productive cows has been associated with poorer reproductive
performance (Pryce et al., 1999). Cows with the highest milk production tend to have the
highest incidence of infertility, but other factors may be affecting reproduction (Butler,
2000).
The need for more milk production per cow can be explained by an increase in
demand for dairy products. A growing population has demanded more dairy products
and forced the producer towards more production per cow. This growing trend toward
more production per cow has led to a smaller number of dairy cows meeting a high
demand. Animals are managed so that pregnancy must be established during a highly
stressful time for the animal. Animals are usually inseminated around day 60-75 of
lactation, the time when peak production is reached and animals are beginning to recover
from a loss of body weight (reviewed by Lucy, 2001). Lifetime milk production of an
individual cow depends on whether the animal can become pregnant and return for
another lactation. Pregnancy drives the lifetime productivity of a dairy animal because
parturition results in lactation. Declining fertility in the dairy industry is probably a
combination of physiological and management factors that have an additive effect on
reproductive efficiency (reviewed by Lucy, 2001).
5

The decline in reproductive efficiency has been documented in several
publications. Butler performed a review (1998) and reported a decline in first-service
conception rates from approximately 65% in 1951 to 40% in 1996 on farms studied in
New York. Casida et al. (1961) reported that cows artificially inseminated at observed
estrus in the 1950s typically reported conception rates of 55%. Dransfield et al. (1998)
performed a review of the literature to report conception rates of 45% for inseminations
at observed estrus. The fact that conception rates have decreased by such a significant
percentage indicates that a problem may exist with establishment of pregnancy in dairy
cattle in the United States.
Dairy cattle in the United States are not the only cattle experiencing a decline in
reproductive efficiency.

Similar decreases have been reported for first-service

conception rates in Ireland (Roche et al., 2000), Australia (Macmillan et al., 1996) and
the United Kingdom (Royal et al., 2000). A decline in European countries may be due to
a move toward selection for high milk yield United States genetics, without changing
local management and feeding practices (reviewed by Lucy, 2001). Nevertheless, poor
reproductive efficiency is a worldwide problem affecting the dairy industry (reviewed by
Lucy, 2001).
The extent of reproductive decline is poorly documented because many dairy
producers do not maintain adequate reproductive records. The Dairy Herd Improvement
Association (DHIA) is an association that collects herd records for milk production,
reproduction, and nutrition. An individual producer must willfully participate and pay for
the services that DHIA offers. Records on every herd participating in the program are
kept in Raleigh, NC, in the Dairy records Management Systems (DRMS). Silvia et al.
6

(1998) reviewed the DHIA records for dairy producers in Kentucky. Silvia reported an
increase in services per conception of 1.62 to 2.91 from 1972 to 1996. Lucy (2001)
observed increases in services per conception, days open, and days to first insemination
in 143 dairy herds continuously enrolled in the DHIA record system from 1970 to 1999.
Lucy (2001) reported that the greatest decline in reproductive efficiency of these herds
occurred after the mid-1980s.

The data obtained are not necessarily a good

representation of the US dairy herds because producers must voluntarily enroll in the
dairy testing program. Nevertheless, data indicate that a reproductive efficiency problem
has developed over the past decades.
The decline of reproductive efficiency has been established through DHIA
records and personal communication between producers and veterinarians nationwide.
The cause of this decline is usually associated with increased milk production and a
combination of other management factors.

The 2001 USDA National Agricultural

Statistics service showed that nearly 30% of all dairy cows in the United States were
found on farms of 500 or more cows. The number of herds with fewer than 200 cows has
decreased, while the number of farms with greater than 200 cows has increased. These
statistics indicate that the current trend is a consolidation of the dairy industry into large
farms with more cows (reviewed by Lucy, 2001).
In order for a producer to expand their lactating herd, the producer must purchase
or maintain replacement animals. Stahl et al. (1999) reported that pregnant heifers or
first-lactation cows are often used to expand a dairy. First-lactation cows have a lower
energy balance because they consume less, and they require energy for lactation and
growth. Lower energy balance in first lactation cows has been associated with delayed
7

intervals to first ovulation (Lucy et al., 1992). This delayed ovulation in animals with
lower energy balance may explain why the first lactation has been identified as a risk for
conception failure (Loeffler et al., 1999). Many herds have a large percentage of firstlactation cows because culling practices usually lead to the removal of older cows.
Reduced reproductive efficiency in first-lactation cows may be the reason producers have
seen an overall reduction in reproduction during this expansion era.
Inbreeding is another factor that may influence reproductive performance in an
expanding dairy industry. The breeding of dairy cows in the past few decades has moved
towards maximizing milk production.

The use of artificial insemination allows a

producer to use a desired bull many times. Artificial insemination can increase the
occurrence of inbreeding if a producer is not careful with their matings. Hermas et al.
(1987) concluded that a 1% increase of inbreeding led to a 0.17 increase in services per
conception, a 2-day increase in days open, and a 3.3% decrease in conception rate. If
these estimates are correct, inbreeding could be the sole cause of an increase of 7 days
open, 0.6 increase in services per conception, and a 12% decrease in conception rate
since 1980 (Hansen, 2000). Present levels of inbreeding are approximately 5% (Hansen,
2000). Hansen (2000) predicts that levels of inbreeding will reach 10% by the year 2020.
Inbreeding is an aspect of the growing dairy industry that must be monitored, but it is
probably not the only reason for decreased reproductive efficiency.
Numerous factors could have contributed to the decline in reproductive
performance in the dairy industry over the past two decades. Unfortunately, few research
programs in the United States concentrate on reproduction in the dairy cow. This fact
leads to many assumptions about why a decrease in reproductive performance has been
8

experienced. Further research is needed to identify why reproduction has declined, and
what can be done to improve the reproductive efficiency of the dairy cow.
2.2 Embryonic Development
2.2.1 The sperm and oocyte fusion
The development of an embryo occurs over several different stages: fertilization,
1-cell stage, 2-cell stage, 4-cell stage, 8-cell stage, 16-cell stage, morula, blastocyst,
expanded blastocyst, hatching blastocyst, maternal recognition of pregnancy, and
placental attachment (reviewed by Bazer et al., 1993). One must understand each of
these stages in order to identify problems that may cause embryonic mortality.
Fertilization requires three steps to take place: sperm migration through the
reproductive tract, sperm attachment and migration through the zona-pellucida, and
fusion of sperm and oocyte membranes. Sperm first travels through the vagina, cervix,
and uterus, where it begins preparation for fertilization. Sperm preparation, known as
sperm capacitation, begins in the uterus and is completed in the isthmus of the oviduct
(reviewed by Bazer et al., 1993).
A sperm cell basically consists of the head, mid-piece, and tail. The head is the
area in which the chromatin is carried. Chromatin comprises the DNA of a haploid
nucleus (reviewed by Bazer et al., 1993). A caplike structure called the acrosome covers
the anterior end of the head. This acrosome cap carries enzymes that will be used to
penetrate the membranes of the zona pellucida (Tulsiani et al., 1998). Energy for the
motility of the sperm cell is generated in the mid-piece. The purpose of the sperm tail is
providing a means of travel to the oocyte, and penetrating the oocyte. The oocyte
consists of several layers that the sperm must penetrate: the cumulus oophorus, zona
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pellucida, perivitelline space, and vitelline membrane. Physical properties of the sperm
and oocyte allow each of them to successfully merge and complete the act of fertilization
(reviewed by Bazer et al., 1993).
All physical aspects of the sperm and oocyte contribute to the penetration and
fusion of genomic properties of each. The presence of a sperm triggers events that
change the membrane potential of the oocyte. Binding of the sperm to the zona pellucida
is a receptor mediated event (Tulsiani et al., 1998). The specific sperm receptor has been
identified as the ZP3 glycoprotein (Bleil and Wasserman, 1980).

Only an intact

acrosome can bind to this receptor. Once the sperm binds to the zona pellucida, the
sperm binding protein stimulates events that lead to the fusion of the plasma membrane
and the acrosomal membrane. The acrosomal membrane of a sperm cell contains a
lysosome that forms around the anterior portion of the nucleus. This lysosome contains
enzymes that are responsible for digesting the zona pellucida so entry of the sperm may
occur. The tail movement of the sperm is also used for entry into the zona pellucida.
Once the sperm has penetrated the zona pellucida, it moves into the vitelline space and
contacts the vitelline membrane. Following fusion with the oocyte, the sperm nuclear
envelope breaks down. Chromatin from the sperm and oocyte migrate to the center of the
ovum, and the chromosomes of each intertwine. These two haploid cells now produce a
diploid cell which contains the genomic make up of the offspring. These steps conclude
the act of fertilization and lead to the development of a 1-cell embryo (reviewed by Bazer
et al., 1993).
The development of the embryo continues at the one-cell stage and is taken
through several stages until a fetus is formed. The joining of the two haploid cells, or
10

chromatin, will come together to form a diploid cell. It is at this stage that the embryo is
considered to be one-cell. The one-cell embryo will rapidly divide into 2, 4, 8, and 16
cells through a process called mitosis. The dividing of the cells is referred to as cleavage
division. Mitotic division results in daughter cells, in which each cell receives the full
assortment of chromosomes.

Cells that are undergoing cleavage are known as

blastomeres. Following the formation of a 16-cell embryo, the blastomeres begin to form
tight junctions with one another. These blastomeres flatten on each other to form a
rounded embryo and an internal cell mass. Surface microvilli are also formed and
become asymmetrically positioned in a process called polarization (reviewed by Bazer et
al., 1993).
The combined processes of flattening and polarization are referred to as
compaction (reviewed by Bazer et al., 1993). The formation of tight junctions and
compaction result in the separation of cells. One population of cells produces the inner
cell mass and gives rise to the embryo and fetus.

The other cells produce the

trophectoderm. The trophectoderm acquires the ability to transport nutrients and water
from the uterine environment to the blastocoelic cavity. The continued accumulation of
fluid due to compaction causes the blastocyst to expand, forming an expanded blastocyst.
Eventually a crack develops in the zona pellucida, and the blastocyst is released, forming
a hatching blastocyst. The steps by which the embryo forms all occur inside the zona
pellucida, but the embryo continuously moves down the reproductive tract while
developing inside (reviewed by Bazer et al., 1993).
The portion of the reproductive tract in which the embryo travels to the uterus is
called the oviduct. The oviduct consists of four distinct regions: infundibulum, ampulla,
11

ampullary-isthmic junction, and isthmus (reviewed by Ellington, 1991). An oocyte is
released by the ovulatory follicle into the infundibulum and transported to the ampulla.
The ampulla is the area in which the oocyte is matured and prepared for sperm binding.
Sperm are stored in the isthmus where they undergo capacitation and are prepared to
fertilize the oocyte. The sperm and oocyte meet at the ampullary-isthmic junction and
are bound together. A fertilized embryo will remain in the ampullary-isthmic junction for
2.5-3 days. Early embryos are unable to cleave and develop in the uterus; therefore, they
must remain in the oviduct until approximately 72 hours post ovulation.

Once the

embryo has reached the 16-cell stage, it travels into the uterus, where it remains for the
duration of gestation (reviewed by Ellington, 1991). The uterus consists of the uterine
body and two horn-like structures on either side. The horns each have an ovary at the tip,
which will provide adequate hormones for maintaining pregnancy (reviewed by Bazer et
al., 1993).
Hatching of the blastocyst occurs around day 9-11 of development. The shedding
of the zona pellucida is coincided with an accelerated growth of the blastocyst. This
rapid growth involves the enclosure of the blastocoele (inner cell mass) to form a
bilaminar blastocyst. The bilaminar blastocyst elongates to allow for attachment in the
uterus later. The extraembryonic endoderm cells involved in the closure develop the
equivalent to the yolk sac. This membrane will be involved in supplying nutrients to the
early embryo. Day 13 in the bovine species exhibits a logarithmic elongation of the
blastocyst. The corpus luteum (CL) that is responsible for pregnancy maintenance is
located on the ovary ipsilateral to the uterine horn containing the embryo. Generally, the
elongated blastocyst will develop in the horn that has an ovary with a CL. The embryo
12

will develop in the uterine horn until later elongation into the uterine body (reviewed by
Bazer et al., 1993).
2.2.2 Maternal recognition of pregnancy
Once the embryo is elongated and residing in the uterine horn, other changes must
take place. Certain processes must take place in order for the mother’s body to recognize
that she is pregnant. This process is known as maternal recognition of pregnancy. The
conceptus must release certain proteins in order for pregnancy recognition to take place.
Bovine interferon-tau (IFN-τ) is the protein responsible for the maintenance of pregnancy
(Bowen and Burghardt, 2000). Production of PGF2α begins towards the end of a natural
estrous cycle by the endometrium. This release of PGF2α stimulates the release of OT by
luteal cells, which enhances the release of PGF2α by the endometrium (Fuchs, 1987).
Endometrial PGF2α excretion and continued OT release by the corpus luteum (CL) ensure
a pulsatile release of PGF2α. This pulsatile PGF2α lyses the CL; therefore, restarting the
estrous cycle or causing embryonic mortality (Bowen and Burghardt, 2000). Interferontau must be released by the conceptus in order to prevent OT from causing luteal death
(Bowen and Burghardt, 2000).
Bovine conceptus secretory hormones will enter the uterus about day 15 and
inhibit uterine production of PGF2α.

The endometrium of pregnant cows does not

respond to estradiol- and OT-induced uterine production of PGF2α, and has very low
estrogen and oxytocin receptors on days 14-21, as opposed to cycling nonpregnant cows
(reviewed by Bazer et al., 1993). Prostaglandin F2α is the luteolytic agent in cattle, and is
primarily secreted from the surface of the epithelium of the uterus. The epithelium of the
uterus is a glandular surface responsible for the release of regulatory proteins. Oxytocin
13

is responsible for the pulsatile release of PGF2α, resulting in the lysing of the CL.
Oxytocin stimulates the release of PGF2α from the endometrium, and uterine oxytocin
receptors (OTR) to determine the sensitivity of the endometrium to OT stimulation. In
order for pregnancy to be maintained, the pulsatile action of the PGF2α must be
eliminated. Interferon-tau is produced by the trophoblast of the conceptus (Thatcher et
al., 1997). The secretion of this protein decreases the OTRs and therefore decreases the
sensitivity of the endometrium to OT stimulation (Okuda et al., 2002).
mechanism of how IFN-τ operates is not completely understood.

The exact

One mechanism

theorized is that IFN-τ operates by reducing estradiol receptor number, therefore reducing
estrogen-induced increase in OTR numbers. Studies have indicated that IFN-τ also
decreases the amount of cyclooxygenase-2 (COX-2), which is a precursor to the
production of PGF2α.

This mechanism of decreasing COX-2 is believed to be

independent of changes in OTR (Xiao et al., 1999).
Although IFN-τ reduces OTRs in the endometrium, this is probably not the sole
effect the embryo has on PGF2α suppression.

Linoleic acid has been identified as

inhibiting PGF2α synthesis in cows (Thatcher et al., 1994). This inhibitor is released by
the endometrium of pregnant cows. Linolenic acid competes with arachidonic acid for
the active site on the cyclooxygenase enzyme. The cyclooxygenase enzyme is the key
rate-limiting enzyme responsible for the conversion of arachidonic acid to precursors of
PGF2α production (Xiao et al., 1999). Interferon-tau can suppress the detrimental effects
of PGF2α by acting on the oxytocin receptor gene. The oxytocin receptor gene expression
is induced by estrogen. Studies suggest that IFN-τ affects oxytocin receptors through
inhibitory actions on the estrogen receptors. Type 1 interferons, such as IFN-τ, activate
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protein kinase C (Thatcher et al., 1997). Protein kinase C reduces concentrations of
estrogen receptors by increasing the turnover of estrogen receptor mRNA. Bazer et al.
(1997) suggests that binding of type 1 interferon to its receptor activates the latent
kinases, JAK1, and tyk2, which phosphorylate tyrosine residues of signal transducers and
activators of transcription 1 (STAT1), STAT1A, and STAT2. The activation of kinases
JAK1 and tyk2 leads to a cascade of mechanisms that activate the negative transcription
factor IRF-2. Bazer’s studies suggest IFN-τ suppresses the estrogen receptor directly by
binding to an IFN-τ responsive element in the estrogen receptor gene.

The exact

mechanism of how IFN-τ down regulates the negative effects of OT and its receptors is
not fully understood (Demmers et al., 2001).
The uterus must undergo critical changes in order for the embryo to survive. The
exact changes that are necessary are not fully understood. The presence of progesterone,
produced by the CL, stimulates the glandular epithelium of the uterus. This epithelium is
responsible for the secretion of proteins that become essential for conceptus development.
Exact proteins secreted at the time of conceptus entrance into the uterus have not been
identified in the bovine. Human, pigs, and rats have been studied extensively, but the
regulatory proteins are mainly species specific. It is known that the growth factor,
insulin-like growth factor II (IGF-II), produced by the uterine tissue and the embryo are
essential for embryonic survival (reviewed by Bazer et al., 1993). Though not much is
known about the precise secretions needed for conceptus survival in the bovine uterus,
certain known proteins are essential.
Changes in protein concentrations and physiological changes from the embryo
and the uterus are needed for embryonic attachment. The bovine trophoblast will first
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develop finger-like villi (papillae) that will project into the lumen of the uterine glands.
The papillae will provide a temporary attachment. A loss of trophoblastic microvilli
allows for close contact with the uterine epithelial microvilli. The uterine epithelium
presses into the trophoblastic surface, interlocking with the cytoplasmic projections on
the trophoblastic surface. This close surface contact between the epithelium of the uterus
and the trophoblast of the conceptus allows a redevelopment of trophoblastic microvilli,
and a more complex attachment (reviewed by Bazer et al., 1993).
2.3 Causes of Embryonic Mortality
Reproductive wastage is a major cause of production loss in the beef and dairy
industry. Fertilization failure and embryonic mortality are suggested to be the main
causes of reproductive wastage (reviewed by Ayalon, 1978). Several factors are known
to contribute to early embryonic mortality. Nutrition, genetic make-up, heat stress, and
management techniques are the main factors that have been examined through research.
Early embryonic mortality is referred to as the losses experienced between fertilization
and day 42 of gestation (Dunne et al., 2000). Nutrition is thought to be a major factor
contributing to reproductive failure in dairy animals.
Poor nutrition has always been directly associated with poor reproductive
performance in dairy cows (Butler, 2000). All dairy animals will experience a negative
energy balance following parturition (O’Callaghan and Boland, 1999).

A negative

energy balance occurs when the animal is unable to consume enough nutrients to account
for the milk produced. In order to meet the nutrient demands of high milk production
following parturition, the animal will mobilize energy from its body reserves. This
process causes a loss of weight for the individual early in lactation. The association
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between negative energy balance and weight loss leads to a reduction in body condition
score. Body condition score (BCS) is a tool utilized by producers to evaluate the amount
of reserves possessed by an animal. The dairy industry uses a scale of 1-5. A one score
indicates a severe loss of reserve fat, usually associated with starvation. A two score is
more commonly seen in the early lactation animals. A score of five is excessive fat
reserves over the entire body; usually no bones are distinctly visible. A negative energy
balance has been shown to have a direct association with BCS (Snijders et al., 2001).
Cows that experience weight loss early postpartum will exhibit a low BCS, and
experience a negative energy balance comparable to the BCS (Snijders et al., 2001). A
low BCS has been shown to have a direct association with poor reproductive
performance of dairy animals (Snijders et al., 2001).
Nutritional factors such as BCS and overall intake have been shown to have an
effect on reproductive performance. Severe body condition losses have been associated
with a lower conception rate at first service (Butler and Smith, 1989). This information
indicates a link between the amount of body reserves and the chance of establishing
pregnancy. High nutritional intake has also shown negative effects on the developmental
capacity of embryos (O’Callaghan et al., 2000). Animals grouped in high and low intake
groups were compared for reproductive performance. The study indicated that animals
experiencing high intake had lower conception rates on the first service (O’Callaghan et
al., 2000). High intake is needed for animals to compensate for high milk production,
and the loss of body reserves in early lactation. The mechanism of how high intake
affects reproduction has been studied, but is not fully understood.
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The relationship between high intake and poor reproduction may be more
associated with the oocyte than the embryo. Studies revealed that high dietary intake and
high metabolic load are detrimental to oocyte development and the establishment of
pregnancy (O’Callaghan et al., 2000). Supplementation of dietary fats through ration
balancing has shown to slightly improve the developmental competence of the oocyte.
Dietary fat supplementation is known to increase the size of preovulatory follicles (Lucy
et al., 1993), increase the number of follicles (Wehrman et al., 1991), and increase the
growth rate of dominant follicles (Oldick et al., 1997). Studies have also shown that
dietary fat supplementation increases the longevity of the corpus luteum (Williams, 1989)
and increase production of progesterone (Hightshoe et al., 1991).
The increase of dietary fat in an animal’s ration provides a direct increase in
conception rate (Staples et al., 1998). The use of dietary fat to increase reproductive
performance is not without negative attributes. Increasing fat content of the diet can
cause a dramatic weight gain, and result in metabolic problems later in lactation. The
reproductive parameters are increased, but only minimally enough to see significant
differences statically. The slight differences seen reproductively usually do not outweigh
the metabolic problems experienced in later lactation. The method of increasing dietary
fat is used, but used very carefully. The need for dietary changes to increase reproductive
performance is mainly due to high milk production in early lactation. The genetic makeup of an animal is a contributing factor to high milk production.
High milk production is a genetic aspect that is examined by every dairy breeder
in the industry. Increased production costs have forced producers to obtain as much milk
from each animal as possible. Ideally this allows a more efficient operation and a lower
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cost overall.

High milk yield has long been associated with poor reproductive

performance. Milk yield genetics are determined by examining the performance of the
animal’s mother, and her father’s daughters. Performance evaluation calculates into a
number known as genetic merit. Genetic merit predicts the productive performance of an
animal based on her mother and siblings’ milk performance. Studies have examined the
effects of milk genetic merit on reproductive performance (Snijders et al., 1999;
O'Callaghan et al., 2000; Snijders et al., 2001).
Reproductive performance comparisons of high and medium genetic merit
animals have shown that high genetic merit animals have poorer reproductive
performance (Snijders et al., 1999; Snijders et al., 2001). High genetic merit (HGM)
cows are animals that are bred to produce the maximum amount of milk. Medium
genetic merit (MGM) cows are bred to produce an average amount of milk compared
over the entire breed.

Studies examining nutritional values of HGM and MGM cows

were coupled with examining reproductive parameters (O'Callaghan et al., 2000).
Several differences have been seen between HGM and MGM cows that indicate genetics
play a major role in reproductive performance by influencing milk production and body
condition (Snijders et al., 1999; Snijders et al., 2001). Snijders et al. (1999) collected
oocytes form high and medium genetic merit cows. The number of oocytes collected did
not differ between the two groups, but percent cleavage rate and number of blastocysts
formed were significantly lower for high genetic merit cows (Snijders et al., 1999). High
genetic merit cows also had a lower body condition score at the time of calving (Snijders
et al., 1999). This data indicates that BCS may have an impact on oocyte quality. In a
later study Snijders and coworkers (2001) looked closer at the relationship of BCS and
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reproductive performance. HGM cows exhibited a lower body condition score during
early lactation than MGM cows (Snijders et al., 2001). A lower body condition score
indicates a greater loss of body fat and decreased nutrients for oocyte development.
Glucose and IGF-1 binding proteins were significantly lower for HGM cows at 2-10
weeks postpartum (Snijders et al., 2001). Glucose is needed for proper ovary function,
and a lack of excessive glucose will result in poor ovulatory function (Snijders et al.,
2001). HGM cows also exhibited a higher dietary intake than MGM cows (Snijders et
al., 2001).

Studies performed by O’Callaghan and coworkers (2000) indicated that

animals with a higher intake experienced a lower reproductive performance.
The comparison of HGM and MGM cow’s nutrition and reproductive
performance indicated that genetic merit is a major contributing factor in reproductive
failure. Snijders et al. (2001) indicated that the glucose and IGF-1 were lower for HGM
cows at 2-10 weeks postpartum. HGM and MGM cows were bred during this same study
and compared. The plasma concentrations of glucose did not differ between HGM and
MGM cows that established pregnancy on the first service (Snijders et al., 2001). This
information indicates that genetic merit is a greater negative factor than nutrition for
reproductive problems (Snijders et al., 2001). Nutrition would have been a greater
problem, according to this study, if the plasma concentrations of glucose had been lower.
Snijders and coworkers’ (2001) study also indicated that HGM cows had a lower
conception rate on first and second services when compared to MGM cows. There were
also more HGM cows not pregnant at the end of the breeding season than MGM cows
(Snijders et al., 2001).

Snijders and coworkers (2001) found no differences in the

number of services per conception for HGM cows, but more services were needed for
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HGM cows as a group. These studies performed by Snijders et al. (1999, 2001) indicate
that genetic merit plays a greater role in reproductive failure than once thought.
Heat stress is an environmental factor that is known to negatively influence
reproductive performance (reviewed by De Rensis and Scaramuzzi, 2003). De Rensis
and Scaramuzzi (2003) conducted a review of the research that indicates heat stress can
have a negative effect on the oocyte, ovary, and early embryonic development. All of
these negative factors lead to a decrease in reproductive performance, pregnancy rates,
and an increase in days open. Decreases in pregnancy rates due to heat stress have
always plagued the animal industry and cost producers money.
Early studies in reproductive performance indicated that heat stress was causing a
decrease in pregnancy of dairy cows. Stott and Williams (1962) found that pregnancy
rates were decreased by the summer heat of Arizona. A pregnancy rate of 61.6% was
reported in May, and the percentage fell throughout June and July.

The lowest

conception rate (17.1%) occurred in August. September recorded a 58.2% conception
rate, which indicates that the heat had a dramatic effect on pregnancy rates. However,
heat was not the sole factor on the decreased conception rate during August. Humidity
also seems to affect pregnancy, as the percentage of humidity was greatest during the
month of August.
Investigators hypothesized that another reason conception rates were low during
the summer months was lack of estrous behavior. Cows reportedly experienced long
estrual intervals. Long estrual intervals were identified as cows that were found not
pregnant at the 35 day pregnancy check, but did not exhibit estrus before 35 days post
insemination. The long estrual intervals indicate that the heat affects the estrous cycle in
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some manner (Stott and Williams, 1962). The mechanism by which heat stress affects
the estrous cycle of the cow is not fully understood by investigators in this field.
Heat stress is known to negatively affect the ovary and embryo. Intensive study
of the ovary during times of heat stress has provided some insight of the mechanism.
Howell et al. (1994) examined the growth and function of the corpus luteum during
spring and summer. Summer months resulted in heat stressed dairy cows due to high
ambient temperatures and relative humidity. Spring months allowed animals to remain at
a thermoneutral temperature. Howell and coworkers reported that season did not affect
the size of the corpus luteum, or the length of the luteal phase (Howell et al., 1994). It
was also reported that the peak progesterone concentration was significantly lower for the
animals experiencing heat stress during the summer (Howell et al., 1994). The authors
concluded that hyperthermia may alter the functional characteristics of the corpus luteum
cells (Howell et al., 1994).
Wilson et al. (1998) found that ovaries under the influence of heat stress had
fewer follicles. Wilson’s finding indicates that there is a disturbance in the follicular
growth and function process. Small ovulatory follicles and large subordinate follicles
were found on ovaries of heat stressed animals. Wilson et al. (1998) also found that the
cows undergoing heat stress had lower concentrations of estradiol in blood serum. The
low levels of estradiol may contribute to the small ovulatory follicle size. Estradiol also
plays an important role in the luteolysis process in the cow. Estradiol is released from the
preovulatory follicle and increases blood concentrations. Increased concentrations of
estradiol will up-regulate the synthesis of the endometrial oxytocin receptor and activate
enzymes associated with PGF2α production.
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Oxytocin and estradiol bind to their

respective uterine receptors to initiate the pulsatile release of PGF2α.

The pulsatile

release of PGF2α leads to the lysing of the corpus luteum and another estrous cycle. The
lack of estradiol delays the luteolysis process and allows the corpus luteum to remain
intact (Wilson et al., 1998).
The failure of luteolysis is most likely why Stott and Williams (1962) observed a
longer estrual interval during hot summer months. Wilson et al. (1998) concluded that
heat stress inhibited follicular growth during the preovulatory period. Inhibition, as seen
by a decrease in estradiol level, may cause small dominant follicles and excessive
follicular waves each estrous cycle. The conclusions were interpreted as an abnormal
ovarian function due to heat stress (Wilson et al., 1998). The effects of heat stress on
ovarian function have been linked to a negative effect on embryonic development.
Poor follicular function leads to an incompetent oocyte. Al-Katanani et al. (2002)
collected oocytes from warm and cool season ovaries. These oocytes were cultured and
fertilized in vitro. Oocytes and cleaved embryos from warm season collections had lower
blastocyst development than cool season collections (Al-Katanani et al., 2002). There
was no reduction of cleavage rate of oocytes from warm season oocytes. This suggests
that heat stress does not affect oocyte maturation, sperm binding, and fertility. Zygotes
from warm season oocytes had a reduced competence to develop to blastocyst. These
findings suggest that the effects of heat stressed oocytes greatly affect early embryonic
development (Al-Katanani et al., 2002). Edwards and Hansen (1997) reported a reduced
2 and 4 cell embryo development to blastocyst due to heat stress. The development of
compacted morulae was not affected by heat stress. It was concluded that heat stress has
the greatest effect on early embryonic development. The embryo seems to develop a
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resistance to heat stress following day 3 of development, and becomes less susceptible as
it develops (Edwards and Hansen, 1997). The fact that heat stress has a negative effect
on early embryonic development leads to questions of how to prevent these effects.
Early studies indicated that embryonic loss due to heat stress occurred before day
35 of gestation (Stott and Williams, 1962). It was believed that cooling animals under
heat stress prior to insemination would help establish pregnancy. Al-Katanani et al.
(2002) cooled animals to a temperature of 39.2 ± .1 °C for 42 days using fans and foggers
before predicted ovulation. Reports stated that the oocyte quality had not improved
following this cooling (Al-Katanani et al., 2002). Conclusions stated that cooling was not
effective for several possible reasons: 1) the degree of cooling was not sufficient to
prevent adverse effects of heat stress; 2) heat stress damaged the oocyte earlier in
development than cooling was initiated, or 3) seasonal effects represent factors other than
heat stress (Al-Katanani et al., 2002). Conclusions from various studies indicate that heat
stress affects the oocyte early in development. It has been reported that primary follicles
begin growth about 84 to 85 days before ovulation (Picton et al., 1998; McNatty et al.,
1999). Adverse effects of heat stress on the oocyte potentially begin during the first steps
of antral follicle development. These general conclusions correspond with poor fertility
in early cool seasons. This may be due to oocytes experiencing heat stress during
summer heat and being released as damaged oocytes in early cool seasons.
Studies are currently being conducted to further understand the effects of heat
stress on early oocyte development. Heat stress is known to decrease reproductive
performance of lactating dairy cows. The mechanism by which heat stress affects the
oocyte, ovary, and early embryo is not fully understood. Heat stress is one of several
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factors that cause early embryonic mortality. Nutrition, genetic merit, milk production,
and heat stress all can have negative effects on reproductive performance, and all must be
monitored in order to gain better reproductive performance.
2.4 PGF2α Association With Early Embryonic Loss
Prostaglandins are biochemical compounds derived from arachidonic acid, a
polysaturated fatty acid. Prostaglandins are involved in several physiological processes
such as inflammation, production of pain and fever, control of blood vessel tone and
arterial blood pressure, luteolysis, and blood clotting (Nett, 1976; Seibert, 1994; Blatteis
and Sehic, 1997). The possible effects of prostaglandin on the early embryo are the focus
of the following review.
Studies using “short cycle” cows indicate that a high level of PGF2α in the uterus
may also cause early embryonic loss. Short cycle animals are those that experience an
estrous cycle less than or equal to 14 days (Schrick et al., 1993). A normal cycling
animal will have an estrous cycle of approximately 21 days.

Short cycle animals

experience a premature release of PGF2α by a postpartum uterus after first exposure to
progesterone (Cooper et al., 1991). This premature release of PGF2α causes an early
lysing of the corpus luteum. A short cycle is often associated with the first estrus
following parturition (Ramirez-Godinez et al., 1982). Conception rates of 28% were
reported on cows experiencing a short cycle (Butcher et al., 1992). A 56% conception
rate was reported on cows with a normal estrous cycle (Butcher et al., 1992). These
significantly different conception rates indicate that short cycle cows have an improper
uterine environment for the oocyte or embryo, on or before day 7 of embryonic
development (Butcher et al., 1992).
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Schrick et al. (1993) studied the quality of embryos from short cycle cows and
normal cycling cows.

Schrick reported that the quality of embryos at day 6 of

development did not differ in short cycle cows when compared to normal cycling cows.
Pregnancy rates did not differ between short and normal cycling embryos when placed in
a normal cycling uterine environment.

This information indicates that the lower

conception rates seen in short cycling cows are taking place around day 7 or shortly after.
Concentrations of PGF2α from uterine flushings were also recorded by Schrick. Schrick
reported that PGF2α concentrations were much higher in short cycling cows when
compared to normal cycling cows. High uterine concentrations of PGF2α indicate that the
uterine environment in short cycle cows may be too poor for embryonic development.
The findings by Schrick et al. (1993) indicate that the embryo is not affected prior to day
6 of embryonic development in a high PGF2α concentration environment.
The decreased pregnancy rates in short cycling and normal cycling cows have
been suggested to be the result of a regressing corpus luteum. A regressing corpus
luteum will produce and direct oxytocin towards the uterus for continued PGF2α
production. In vitro treatment of 8-cell rat embryos with PGF2α prevented development
to the morula stage (Breuel et al., 1993). The treatment of rabbit embryos with PGF2α
prevented the formation of expanded or hatched blastocysts (Maurer and Beier, 1976).
These studies suggest that embryonic development may be compromised by a direct
action of PGF2α or an embryo toxic factor from the regressing corpus luteum. Seals et al.
(1998) studied in vivo embryonic development in progestogen supplemented cattle with a
removed corpus luteum.

Animals involved in the study were bred and pregnancy

checked at 30 days post artificial insemination (AI). A control group was simply bred AI
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and pregnancy checked. Another group was administered PGF2α following breeding.
The final group was administered PGF2α following breeding and underwent a lutectomy.
Lutectomy is a procedure in which the corpus luteum is ruptured, or removed, in vivo by
applying digital pressure. Animals that underwent a lutectomy and PGF2α administration
had increased pregnancy rates compared to those that were only administered PGF2α.
Seal’s study suggested that a regressing corpus luteum may be needed to elevate
concentrations of PGF2α high enough to lower embryonic survival rates.
Hockett et al. (2004) studied the effects of PGF2α administration on embryonic
development in cattle.

Animals were assigned a control treatment of saline or

administered PGF2α. Hockett reported elevated concentrations of 13-14-dihydro-15-ketoprostaglandin F2α (PGFM), the metabolized form of PGF2α, in the blood of PGF2α treated
animals compared to animals that received saline. A reduction in the quality score of the
day 8-recovered embryos was observed in animals treated with PGF2α. The development
of the embryos between the two treatment groups was also studied. Hockett et al.
reported that many of the PGF2α-treated embryos did not develop beyond the morula
stage, while all of the saline treated embryos had developed to maturity corresponding to
the day of development. Hockett concluded that embryos under the influence of PGF2α
during days 5-8 of development suffer detrimental effects with respect to quality and
development (Hockett et al., 2004).
Scenna et al. (2004a) studied the effects of PGF2α on pre-compacted in vitroderived embryos and compacted in vivo-derived embryos. The study found that addition
of PGF2α to culture medium of pre-compacted embryos had a direct negative effect on the
embryo’s ability to develop to the blastocyst stage. The addition of PGF2α to culture
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medium of compacted in vivo-derived embryos did not affect the embryo’s ability to
develop to blastocyst stage, but did significantly reduce hatching rates. These results
indicate that a negative effect of PGF2α may be occurring as early as or before day 5 of
development. The authors concluded that PGF2α may be disrupting tight junctions to
result in decreased blastocyst development and hatching rates (Scenna et al., 2004a).
2.5 Effects of PGF2α Inhibitors
Nonsteroidal anti-inflammatory drugs (NSAIDs) are drugs that inhibit production
of prostaglandins associated with an inflammatory response (Vane, 1971). Inflammatory
responses are those associated with pain, fever, swelling, redness of tissue, and other
injury related experiences (Vane and Botting, 1998).

The act of manipulating the

reproductive tract during rectal palpation, an act involved in artificial insemination and
embryo transfer, can cause an inflammatory response and the release of PGF2α (Wann
and Randel, 1990; Velez et al., 1991). Prostaglandin F2α exposure to an early embryo can
compromise embryonic survival (Schrick et al., 1993; Breuel et al., 1993; Seals et al.,
1998; Lemaster et al., 1999; Hockett et al., 2004; Scenna et al., 2004a). Prostaglandins
released by an inflammatory response during artificial insemination and embryo transfer
may be inhibited by NSAIDs.
Therapeutic activities of NSAIDs occur through inhibition of cyclooxygenase
(COX).

The enzyme COX is involved in the production cascade required for the

production of prostaglandins. Research has indicated that there are at least two COX
enzymes, COX-1 and COX-2. Prostaglandins that protect the stomach and kidneys from
damage are produced by COX-1. Prostaglandins that contribute to the pain and swelling
of inflammation are produced by COX-2. Selecting NSAIDs to inhibit COX-2 should
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prevent an anti-inflammatory response without damaging the stomach or kidneys (Vane
and Botting, 1998).
Several NSAIDs have been used in research in an attempt to inhibit COX-2,
which should block prostaglandins. Prostaglandins are derived from arachidonic acid,
which is oxygenated by COX-2. Ibuprofen lysinate, aspirin, and flunixin meglumine are
all NSAIDs that have been used in research to attempt to inhibit the production of
prostaglandins. The administration of flunixin meglumine has been shown to result in
lower levels of PGF2α in the blood when administered 4 times daily (Aiumlamai et al.,
1990). The PGF2α concentrations were reduced so to prevent luteolysis of the corpus
luteum and prolong the estrous cycle (Aiumlamai et al., 1990). Treatment with flunixin
meglumine did not alter the PGF2α production cascade permanently.

Animals that

underwent flunixin meglumine treatment experienced a significant decrease of PGF2α
metabolite for 32, 20, and 16 hours following the final treatment. All animals resumed
normal hormonal activity following the conclusion of the treatment end (Aiumlamai et
al., 1990). The intensive treatment of animals with flunixin meglumine indicates that this
NSAID has the ability to inhibit the production of PGF2α and extend the life of the corpus
luteum, which is essential for the maintenance of pregnancy. The fact that flunixin
meglumine has the ability to inhibit PGF2α production leads to the question of whether
PGF2α is released during manipulation of the reproductive tract.
Velez et al. (1991) and co-workers performed a study in which PGFM
concentrations were measured following uterine manipulation. Peripheral concentrations
of PGFM reflect the endogenous uterine production of PGF2α. Animals received gentle
uterine manipulation for 2 minutes at a time. One group received manipulation weekly
29

from days 9-51 postpartum. Another group received manipulation one time between 2935 days postpartum.

Blood collections were taken from each group and PGFM

concentrations were measured. Results indicated that PGFM concentrations elevated
during the weekly manipulation, and elevated for the one time manipulation at day 30
postpartum on average. These results indicated that uterine manipulation does increase
the uterine production of PGF2α (Velez et al., 1991). Uterine manipulation for this study
occurred over a two minute time period, which may be longer than most artificial
insemination and embryo transfer manipulations.
Odensvik and coworkers (1993) performed a study in which the levels of PGF2α
were measured following non-surgical embryo transfer in cattle.

Prostaglandin

metabolite levels in the blood were measured to indicate PGF2α levels. Blood was
collected every 10 minutes, beginning 50 minutes before embryo transfer and continuing
for about 5 hours following embryo transfer. Each transfer was classified as easy,
medium or difficult based on the amount of effort required to insert the catheter in the
correct location of the uterine horn. Standard embryo transfer procedure requires a
rubber catheter to be inserted two-thirds of the way into the uterine horn. Most embryos
are at 7 days of development when transfer is performed; therefore, they must be placed
where development is occurring for a 7 day embryo.

The investigators found no

significant change in prostaglandin F2α metabolite level pattern during embryo transfer.
Furthermore, concentrations of PGFM did not differ between the transfer difficulty
groups. The results of this study indicate that the manipulation of the reproductive tract
during embryo transfer did not increase concentrations of PGFM (Odensvik et al., 1993).
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Studies have been performed in humans and cattle to determine whether NSAIDs
may increase reproductive performance following embryo transfer.

Rubinstein and

coworkers (1999) treated human patients with low-dose aspirin during in vitro
fertilization procedures. The study found that the number of follicles, number of oocytes
retrieved, implantation rate, and pregnancy rates were significantly higher for patients
receiving low-dose aspirin treatment. These results indicate that the NSAID aspirin can
increase reproductive performance and pregnancy rates by potentially inhibiting
prostaglandin (Rubinstein et al., 1999).
Lemaster et al. (1999) performed a study indicating that the NSAID flunixin
meglumine was effective in blocking the negative effects of PGF2α and therefore
increasing pregnancy rates. Animals were treated with oxytocin + flunixin meglumine
(OT + FM), OT, or OT + lutectomy (LUT) following breeding. Lemaster et al. reported
that animals administered OT + FM resulted in pregnancy rates similar to that of the
controls. Pregnancy rates of OT and OT + LUT treated animals were significantly
reduced compared to controls and OT + FM. This information indicates that flunixin
meglumine may inhibit the detrimental effects of PGF2α on early embryonic development
(Lemaster et al., 1999).
Elli and coworkers (2001) performed study using ibuprofen lysinate, an NSAID,
in bovine embryo transfer. Embryos were transferred into heifers that were classified as
being acceptable to receive an embryo. Half of the animals received an injection of
ibuprofen lysinate before embryo transfer; the other half received a placebo treatment.
Pregnancy rates for animals receiving ibuprofen lysinate and controls were 82% and 56%
respectively. A significant improvement was reported for those animals that received
ibuprofen lysinate (Elli et al., 2001).
31

The use of flunixin meglumine has been studied in cattle in an attempt to improve
reproductive performance during embryo transfer. McNaughtan et al. (2001) conducted a
study in which heifers were administered FM prior to embryo transfer. Pregnancy rates
were not statistically improved with administration of FM (McNaughtan et al., 2001).
However the authors reported that a logistics analysis of the odds ratio indicated that
heifers were 1.22 times more likely to become pregnant when administered FM prior to
transfer (McNaughtan et al., 2001). Scenna et al. (2004b) performed a study in which
animals were administered flunixin meglumine or saline at the time of embryo transfer.
The results of the study indicated that a significant improvement in pregnancy rates
occurred for those animals administered flunixin meglumine. Animals administered
flunixin meglumine resulted in pregnancy rates of 65%, while animals administered
saline resulted in 60%. Flunixin meglumine also significantly increased pregnancy rates
for quality score 2 embryos (64.5 vs 53.5%; respectively), and morula and blastocyst
stage embryos (64.5 vs 58.9%: 66.5 vs 59.5%; respectively). This administration was a
single dose and resulted in improvement of pregnancy rates by potentially inhibiting the
effects of PGF2α (Scenna et. al., 2004b). These results contradict those of Aiumlamai et
al. (1990) with respect to dosage. Aiumlamai et al. (1990) reported that intensive dosing
(4 doses per day) was required to have positive effects with flunixin meglumine.
Flunixin meglumine is preferred in cattle because it has other therapeutic uses and is
readily available to the animal producer.
Embryo transfer is a procedure that involves many of the uterine manipulations
involved in artificial insemination. Reports indicate that NSAIDs have a positive effect
on pregnancy rates during embryo transfer in humans (Rubinstein et al., 1999) and in
cattle (Elli et al., 2001; Scenna et al., 2004b). The fact that flunixin meglumine has been
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reported to have positive effects is promising for the animal producer.

Flunixin

meglumine could be used during artificial insemination to increase pregnancy rates since
uterine manipulations are similar. The key to flunixin meglumine administration is
discovering the best time to administer the NSAIDS to maximize the possible positive
effect. Embryos are transferred at 7 days of development, but the embryo does not exist
when artificial insemination is performed. Researchers involved in this field predict that
days 4-6 following artificial insemination may be the best time to administer flunixin
meglumine. Studies have not been performed to test this hypothesis.
2.6 Summary of the Literature
Early embryonic death is a problem that plagues dairy producers worldwide.
High milk demands have forced producers to feed highly concentrated rations, breed for
high milk yield, and concentrate more animals in a centralized location. These factors
have contributed to a decline in reproductive efficiency of dairy animals over the past
decades. Research has been conducted in attempts to improve reproductive performance
without compromising milk yield.

Unfortunately, more studies are needed before

acceptable reproductive levels are reached.
The presence of PGF2α has been shown to have a negative effect on early
embryonic development. Controlling PGF2α during early embryonic development may
decrease early loss. Flunixin meglumine has successfully been used to block PGF2α
synthesis in cattle. Flunixin meglumine has also been shown to increase pregnancy rates
when administered immediately following embryo transfer.

The use of flunixin

meglumine on day five following artificial insemination may improve pregnancy rates for
the dairy industry.
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The objective of this study is to determine if administration of flunixin meglumine
on day 5 following artificial insemination can increase reproductive efficiency in
lactating dairy cattle.
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3. Materials and Methods
All experimental materials were provided by Schering-Plough Animal Health
Corporation (SPAHC; Union, NJ) unless otherwise noted.

The experiment was

conducted from September, 2002 through April, 2003 at the University of Tennessee
Knoxville Experiment Station (KES) Dairy Unit. Animal/and nutritional management
were performed as regular facility practices at the KES Dairy Unit. A total of 121
Holstein and Jersey cows (Table 1) were randomly assigned to receive a treatment of
flunixin meglumine or saline following estrous synchronization and artificial
insemination. Ultimately, 106 animals were used for final data analysis as discussed in
the results section.
All animals involved in estrous synchronization and treatment assignment were at
least 60 days in milk, ≥ 364 kg body weight (BW), and identified as being reproductively
sound by the attending herd veterinarian. Animals underwent estrous synchronization
using a two-injection protocol of Estrumate (cloprostenol, 500 µg). One injection of
Estrumate (2 mL) was administered intramuscularly to initiate estrous synchronization.
Animals were fitted with a radiotelemetric estrous detection system (HeatWatch Estrus
Detection System, DDX, Inc., Denver, CO). Standing estrus was defined as ≥ 3 mounts
of ≥ 2 sec within a 4-hour period as detected by HeatWatch, or visual confirmation of an
animal standing to be mounted by a herd mate. Animals exhibiting standing estrus were
artificially inseminated 12 ± 6 h following first detection of standing estrus utilizing one
0.5 mL straw of semen. Semen was used from various Holstein and Jersey bulls of
proven fertility (semen obtained by University of Tennessee KES).
exhibiting

standing

estrus

following
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the

first

injection

Animals not
of

Estrumate

Table 1. Description of animal numbers and production characteristics.

a

Number Animals

SAL

FM

Cows

106

51

55

1st Lactation

50

24

26

2nd Lactation

30

15

15

3+ Lactation

26

12

14

Holstein

71

34

37

Jersey

35

17

18

rBST

71

34

37

MP (kg/d)a

33.5

33.9

305 ME (kg)b

10,959

10,636

BW (kg)c

528

548

BCSd

2.8

2.9

DIM (d)e

131

149

MP = Milk Production

b
c

Variable

305 ME = 305 Mature Equivalent

BW = Body weight

d

BCS = Body Condition Score (1, thin to 5, fat)

e

DIM = Days in Milk
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received a second injection 11 days following the initial injection. Animals experiencing
standing estrus following the second injection of Estrumate were inseminated as defined
previously. Animals not exhibiting standing estrus following the two-injection protocol
were recycled into the estrous synchronization program for no more than two additional
attempts.
Treatment with flunixin meglumine or saline was randomly assigned between
primiparous and multiparous cows. Treatment was administered intravenously in the
vena cava (FM, 2.2 mg/kg BW; SAL, 1 mL/23 kg of BW) 5 days ± 12 h following
artificial insemination. Body weight was determined using certified scales (Tru-Test
SR2000, Tru-Test Limited, Auckland, New Zealand) immediately prior to treatment
administration. Milk from FM treated cows was discarded for 36 hours (3 milkings)
following treatment as directed by the FDA.
Pregnancy was determined at 28-35 days post artificial insemination by the
presence of an embryo with a heartbeat by transrectal ultrasonography (SIUI, CTS-200V;
Shantou, Guangdong, China) equipped with a 5.0 MHz linear transducer. The ultrasound
technician was blinded with respect to treatment. Any animal not pregnant following
pregnancy determination was not re-enrolled in the experiment.
Additional variables of interest (Table 1) included breed, lactation number (LN),
days in milk (DIM), actual milk production (MP), 305 mature equivalent (ME), BW,
body condition score (BCS), and if the animal was under the influence of recombinant
bovine somatotropin (rBST; POSILAC®, Monsanto Company, St. Louis, MO). Days in
milk was determined on the day of treatment with FM or SAL. Data for 305 ME were
calculated by PC-DART (Dairy Records Processing Center, Raleigh, NC).
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Milk

production was calculated by averaging the daily milk weights (obtained by HerdMaster®
Management System, Alfa-Laval Agri Inc., Kansas City, MO) of 3 days prior, the day of,
and 3 days following treatment. Lactation number was divided into three groups of 1, 2,
and 3+. Days in milk were grouped as high (> 150 d), medium (75-150 d), and low (< 75
d). Daily milk production was grouped as high (> 36 kg), medium (36-27 kg), and low
(< 27 kg). Groups of 305 ME were established as high (> 11,818kg), medium (10,00011,818 kg), and low (< 10,000 kg). Body weight was grouped as high (> 591 kg),
medium (454-591 kg), and low (< 454 kg).

Recombinant BST administration was

determined as whether or not a cow was under the influence of rBST at the time of
artificial insemination. Body condition score was assigned to an individual at the time of
pregnancy determination by one of two qualified technicians.
3.1 Statistical Analysis
Differences in pregnancy rates were analyzed by using Mixed Models of SAS
(SAS, 2000) in a completely randomized design. All cows were equally assigned to
treatment with regards to breed, lactation number, rBST, BCS, BW, MP, DIM, and 305
ME and all interactions as fixed effects were used to compare differences among
treatments. Animal (treatment x lactation x breed) was included as a random effect.
Differences in individual least squares means were evaluated using LSD.

Also,

pregnancy rates were validated using Fisher’s Exact Test (SAS, 2000). This test requires
the fewest assumptions when dealing with percentage data. A value of P < 0.05 was
considered statistically different.
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4. Results
A total of 24 estrous synchronization repetitions were performed during the
course of the study. The 24 replicates averaged 8.3 animals for a total of 199 animals
entering the estrus synchronization protocol. Some of the 199 animals synchronized
were synchronized in more than one replicate due to no response during the previous
synchronization attempt. Seventy-nine animals (65.3%) responded with estrus following
the first injection of Estrumate, while 42 animals (34.7%) responded following the
second injection.

A total of 121 animals responded to synchronization and were

artificially inseminated.
Of 121 cows utilized for the study, two animals were removed from the study
prior to pregnancy confirmation due to ambulatory health problems. Six animals were
artificially inseminated outside of the 12 ± 6 h window following standing estrus. Four
animals were mistakenly artificially inseminated on spontaneous estrus prior to
confirmation of pregnancy. Two animals were treated outside of the 5 d ± 12 h window
following artificial insemination. One animal mistakenly received an injection of PGF2α
by farm personnel prior to pregnancy confirmation.

All fifteen of these animals

mentioned were not included in the data analysis since none of these procedures met the
protocol of the study. A total of 106 animals were ultimately utilized for data analysis
(Table 1).
Administration of FM 5 days following artificial insemination did not improve
pregnancy rates compared to controls (FM= 37.0, SAL = 31.4%; P > 0.10; Figure 1). No
significant differences were detected between FM and SAL treatment within rBST
administration group or lactation group (Table 2). Animals in the high, medium, and low
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Pregnancy Rates
50

A
A

Percent Pregnant

40

30

20

10

0

FM

SAL

Figure 1. Effect of treatment on pregnancy rates. Treatment with flunixin (FM) or saline
(SAL) did not alter pregnancy rates. (A P > 0.10)
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Table 2.

Effect of treatment with flunixin meglumine (FM) or saline (SAL) on

pregnancy rates for cows administered rBST (rBST +) or not administered rBST (rBST -)
and within lactational groups (1, 2, 3 +). Treatment with FM or SAL did alter pregnancy
rates regardless of rBST administration or lactational group (ABCDE P > 0.10).

FM

SAL

rBST -

39.1A

28.0A

rBST +

40.8B

54.2B

LN 1

42.3C

45.8C

LN 2

40.0D

40.0D

LN 3 +

28.6E

8.3E

milk production groups did not differ in pregnancy rates between the two treatments
(Figure 2). Cows in the high, medium, and low 305 ME groups did not differ in
pregnancy rates between the two treatments (Figure 3). Treatment with FM or SAL did
not alter pregnancy rates within low and moderate BCS groups (Figure 4). However,
treatment with FM did increase pregnancy rates for moderate BCS cows compared to low
BCS cows treated with FM (Figure 4). Cows treated with FM or SAL within different
DIM groups did not differ in pregnancy rates (Figure 5).
Factors associated with high milk production were also investigated to determine
if these factors had an effect on pregnancy rates regardless of treatment. Cows in the
high, medium, and low milk production and 305 ME groups did not differ in pregnancy
rates (Figure 6). Breed did not effect pregnancy rates to a significant level. Holstein
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Figure 2. Effect of treatment with flunixin meglumine (FM) or saline (SAL) on
pregnancy rates between low, medium, and high milk production groups. Neither
treatment with FM nor SAL affected pregnancy rates among the different milk
production groups (A P > 0.10).
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Figure 3. Effect of treatment with flunixin meglumine (FM) or saline (SAL) on
pregnancy rates among different 305 mature equivalent (ME) groups. Treatment
with FM or SAL did not result in any significant differences in pregnancy rates
between the low, medium and high 305 ME groups (A P > 0.10).
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FM
70

*
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60
Percent Pregnant

SAL

A

50
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A

*A

30
20
10
0
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Figure 4.

Moderate

Effect of treatment with flunixin meglumine (FM) or saline (SAL) on

pregnancy rates for cows in the low (1-2.5) and moderate (3-5) body condition score
groups. Cows within each body condition score group did not differ in pregnancy rates
regardless of treatment. Cows treated with FM in the moderate body condition score
group did have higher pregnancy rates compared to cows in the low body condition score
group treated with FM (* P < 0.05, A P > 0.10).
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Figure 5. Effect of treatment with flunixin meglumine (FM) or saline (SAL) on
pregnancy rates among different days in milk (DIM) groups. Treatment did not
result in a significant difference in pregnancy rates for cows in the low, medium,
and high DIM groups (A P > 0.10).
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Figure 6. Effect of milk production and 305 ME group on pregnancy rates. Milk
production (MP) and 305 mature equivalent (305 ME) did not have any
significant effect on pregnancy rates (A P > .10).
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cows had a pregnancy rate of 33.8%, while Jersey cows had a pregnancy rate of 42.9% (P
> 0.10). Administration of rBST did have an effect on pregnancy rates by lowering
pregnancy rates for all cows and Jersey cows; however, no differences were detected
within the Holstein breed (Figure 7). Administration of rBST to all cows and Jersey
cows < 100 DIM also lowered pregnancy rates, but no differences were detected within
the Holsteins (Figure 8). Lactation (LN) group tended to decrease (P = 0.09) pregnancy
rates with increasing lactations, but rBST administration did not alter pregnancy rates
within LN group (Table 3). Jersey cows in LN 1 had higher pregnancy rates (72.7%),
while Jersey cows in LN 2 and 3+ were lower (38.5 and 18.2%, respectively; P < 0.05).
However, Holstein cows did not have a significant difference in pregnancy rates with
respect to LN number (1=35.9, 2=41.2, and 3+ =20%; P > 0.10).
Cows with a BCS of ≤ 2.5 and ≥ 3 resulted in pregnancy rates of 31.5 and 37.5%,
respectively (P > 0.10). However, cows with a BCS of ≥ 3 tended to have lower
pregnancy rates when administered rBST (33.4%) compared to those not administered
rBST (60.4%; P = 0.07).
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Figure 7. Effect of rBST administration (rBST +) or no rBST administration (rBST -)
on pregnancy rates. Administration of rBST significantly decreased pregnancy rates in
all cows (A, a P < 0.05). However, administration of rBST did not reduce pregnancy
rates in Holstein cows (B P > 0.10). Jersey cows administered rBST did exhibit a
significant decrease in pregnancy rates (C, c P < 0.05).
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Figure 8. Effects of rBST administration (rBST + or rBST -) on pregnancy rates
for cows < 100 days in milk (DIM).

Administration of rBST significantly

decreased pregnancy rates compared to cows not receiving rBST (A, a P < 0.05).
However, only a breed by rBST administration interaction was noted in Jersey (C,
c

P < 0.05) but not Holstein cows (B P > 0.10).
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Table 3. Effect of lactation (LN) group and rBST administration (rBST +) or no rBST
administration (rBST -) on pregnancy rates within lactation group. Pregnancy rates
tended to decrease between LN 1 and LN 3 + (Aa P = 0.08). Administration of rBST did
not alter pregnancy rates within lactation group (BCD P > 0.10).

1

2

3+

50

30

26

44.1A

40Aa

18.5a

rBST +

42.3B

37.4C

13.6D

rBST -

46.5B

50.0C

41.7D

n

50

5. Discussion

The present experiment was conducted to examine the effects of flunixin
meglumine administration on the establishment of pregnancy following artificial
insemination. Interest was also focused towards other factors (rBST, BCS, DIM, 305ME,
lactation number, and breed) that may have negative effects on reproductive performance
in lactating dairy cattle. It was hypothesized that the stressor of high milk production,
and factors associated with high milk production, would result in an increase of PGF2α
levels 5 days following artificial insemination such that a positive effect of FM on
pregnancy rates would be observed.
No significant differences were detected between FM and SAL treatment for
overall pregnancy rates and within rBST administration group, lactation group, milk
production group, or 305 ME group. A significant affect of treatment on pregnancy rates
was detected with respect to BCS. Animals with a BCS of ≥ 3 experienced increased
pregnancy rates compared to a BCS of ≤ 2.5 when treated with FM. However, all results
should be interpreted with caution due to the limited number of animals available and
utilized in this study.
It is established that FM can be utilized as an adequate inhibitor of PGF2α
(Odensvik, 1995; Konigsson et al., 2003).

Positive effects of FM (a NSAID) on

pregnancy rates seemed logical following the demonstrations of Elli et al. (2001) and
Scenna et al. (2004b) that ibuprofen lysinate and FM, respectively, increased pregnancy
rates following embryo transfer. Aiumlamai et al. (1990) and Odensvik et al. (1998) also
demonstrated that the use of FM could be used to prevent luteolysis and prolong the
estrous cycle. The most detrimental effects of PGF2α on embryonic development tend to
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occur during morula, compacted morula, and blastocyst development (Seals et al., 1998;
Hockett et al., 2004; Scenna et al., 2004a). This stage of development corresponds to day
5-7 of development; thus, treatment with FM on day 5 following artificial insemination
seemed logical. However, treatment on day 5 may have been too early considering
successful uses of FM with embryo transfer (Scenna et al., 2004b) involved embryos at
day 7 of development.
Another factor that may have contributed to similar pregnancy rates between FM
and SAL treatments is the absence of an adequate stressor. It was hypothesized that high
milk production and factors associated with high milk production would serve as an
adequate stressor to increase uterine PGF2α levels. According to the data analysis, milk
production and these factors did not have an influence on pregnancy rates between the
two treatment groups. Previous studies involving embryo transfer and the use of FM
involved the stressor of embryo transfer on animals that did not encounter intense human
contact.

The intense daily contact involved with lactating dairy animals may have

alleviated a stressor commonly involved with beef cattle and dairy heifers. Further
studies with FM in dairy cattle in this research area may need to take place during a time
of additional stress, such as elevated ambient temperature.
Route of administration of FM is another issue that may have resulted in few
differences in pregnancy rates between treatment groups. Three routes of administration
of FM have been studied in the past: oral (granules) (Odensvik, 1995; Odensvik et al.,
1998; Konigsson et al., 2003), intramuscular (Konigsson et al., 2003; Scenna et al.,
2004b;) and intravenous (Odensvik et al., 1993; Odensvik, 1995; Aiumlamai et al., 1990;
Konigsson et al., 2003). Odensvik et al. (1995) and Konigsson et al. (2003) found no
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differences in route of administration and the ability of FM to inhibit the synthesis of
PGF2α. Intensive oral administration of FM granules was found to significantly increase
the length of the estrous cycle (Odensvik et al., 1998).

Intensive intravenous

administration of FM was found to also delay normal luteolysis and prolong the estrous
cycle (Aiumlamai et al., 1990). However, we are unaware of any publications indicating
successful increases in pregnancy rates utilizing an intravenous administration of FM.
Successful increases in pregnancy rates were obtained by Elli et al. (2001) and Scenna et
al. (2004b) utilizing an intramuscular administration of ibuprofen lysinate and FM,
respectively.
First-lactation cows involved in this study experienced a higher pregnancy rate
than cows in lactation 2 and 3+. These results are contradictory to work concerning firstlactation animals and negative energy balance. First-lactation cows have a lower energy
balance because they consume less and have higher energy requirements for growth and
lactation (reviewed by Lucy, 2001). Lucy et al. (1992) associated a lower energy balance
in first-lactation cows with delayed intervals to first ovulation. Negative energy balance,
which may be more severe in first parity has been associated with poor reproductive
performance (Butler and Smith, 1989; Butler, 2000; Snijders et al., 2001; Butler, 2003).
Loeffler et al. (1999) identified first parity as a risk for conception failure at first service.
Several studies indicate that reproductive performance should be better with multiparous
cows.

Milk production is the only logical explanation as to why reproductive

performance was better in first-lactation cows. First lactation cows generally give less
milk than multiparous cows; therefore, the stress of high milk production is not hindering
reproduction. Factors associated with high milk production and actual production has
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been associated with lowered reproductive performance (Snijders et al., 1999;
O’Callaghan et al., 2000; Lucy, 2001; Snijders et al., 2001; Lopez et al., 2004).
The level of milk production of the cattle involved in this study did not result in
significant differences in pregnancy rates for all cows. This data disagrees with the work
of several investigators, which indicate that milk production and genetic selecting for
high milk production can decrease fertility in dairy cattle. O’Callaghan et al. (2000) and
Snijders et al. (2001) both indicated that selecting for high producing cows can decrease
fertility. The work of O’Callaghan et al. (2000) and Snijders et al. (2001) focused on the
nutritional needs of high producing animals. These investigators concluded that selecting
for high producing cows forces a high dietary intake, which leads to a decrease in
reproductive performance. Lopez and coworkers (2004) indicated that high producing
cows have a lowered intensity of estrus. Pregnancy rates for animals in the low, medium,
and high MP groups in this study were 41.4, 41.8, and 18.2%, (P = 0.10) respectively.
Although not statistically different, the high MP group had lower pregnancy rates
numerically. Perhaps a greater number of cows would have resulted in a statistically
significant decrease of pregnancy rates related to milk production.
The stage of lactation for animals involved in this study significantly affected
pregnancy rates.

A significant difference in pregnancy rates was detected between

Holstein and Jersey cows less than 100 DIM. These results are most likely the result of
increased milk production by Holstein cows. High milk production and selection for high
milk production has been associated with poor reproductive performance (Snijders et al.,
1999; O’Callaghan et al., 2000; Snijders et al., 2001; Lopez et al., 2004). Animals less
than 100 DIM and administered rBST resulted in a significant difference in pregnancy
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rates for all cows, and Jersey cows. Cole at al. (1991) reported that treatment with rBST
in early lactation resulted in a downward shift of energy balance that did not return to
control level for 12 weeks. This information may explain why cows less than 100 DIM
and administered rBST had significantly lower pregnancy rates. These cows in early
lactation were most likely already experiencing a negative energy balance, and
administration of rBST may have maintained or increased the severity of the negative
energy balance.
Recombinant BST did have a negative effect on reproductive performance for the
cows involved in this study. A decrease in pregnancy rates was greatest for cows less
than 100 DIM.

Other reports have indicated that rBST has a negative effect on

pregnancy in lactating dairy cattle (Cole et al., 1991; Cole et al., 1992; reviewed by
Dohoo et al., 2003). Dohoo and coworkers (2003) concluded in a review of published
data that rBST use in non-pregnant cows increased the risk of a cow not becoming
pregnant by 40%. Cole and coworkers’ (1991) observations for reduced pregnancy rates
of rBST-treated cows also were detected in early lactation cows. In contrast, Santos et al.
(2004) reported that rBST use tended to reduce embryonic mortality. The mechanism in
which rBST may or may not hinder reproductive performance is not fully understood, but
several theoretical explanations have been published.
The most consistent explanation for decreased reproductive performance due to
rBST administration in the reviewed literature has been a decrease in expression of estrus
(Cole et al., 1991; Morbeck et al., 1991; Waterman et al., 1993; Santos et al., 2004).
Along with decreased estrus expression, it has been reported that rBST is related to
increased days to first service, services/conception, and days open (Cole et al., 1991;
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Morbeck et al., 1991).

The best possible explanation for reduced reproductive

performance related to rBST found in a review of the literature is an alteration in
follicular development (De La Sota et al., 1993; Lucy et al., 1993; Lucy et al., 1994; Lucy
et al., 1995; Kirby et al., 1997a; Kirby et al., 1997b; Santos et al., 2004). De La Sota
(1993) reported that the second largest follicle involved in the second follicular wave was
larger in cows treated with rBST. De La Sota concluded that rBST might change the
relationship between the dominant and subordinate follicles to which the dominant
follicle loses some ability to suppress the subordinate follicle. Lucy et al. (1994) and
Kirby et al. (1997a) reported that rBST treatment resulted in reduced period of
dominance for the first follicular wave and an earlier recruitment of the second wave
follicle. This earlier recruitment allows for an extended period of dominance for the
second wave follicle. Austin et al. (1999) reported that an extended period of dominance
is associated with reduced oocyte viability and subsequent fertility. Kirby et al. (1997b)
reported that cows treated with rBST have reduced FSH; therefore, resulting in a faster
turnover of the dominant follicle and a change in the timing of the follicular waves.
Santos et al. (2004) concluded that all factors related to alteration follicular development
might be the cause of poor reproductive performance associated with rBST. If rBST is
causing a change in the viability of the second follicular wave and beyond, then anything
but a first follicular wave insemination may be in jeopardy. Nevertheless, much research
is still needed to fully understand the effect rBST on reproduction.
Body condition score did not have a significant impact on the pregnancy rates of
the cattle involved in this study. Body condition score has been shown to have a direct
association with energy balance (Snijders et al. 2001). Butler and Smith (1989) reported
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that severe body condition loss was associated with lower conception rate for first
service. Butler (2000) reported that poor fertility in high producing cattle was partially
the result of a negative energy balance. Studies have shown that BCS can be directly
associated with reproductive performance. Gillund et al. (2001) reported that cows with
BCS loss of ≥ 1.25 units following calving were half as likely to conceive at first service
as cows with more modest loss. Stevenson et al. (1999) reported that conception rates
increased by 10% for every unit increased in BCS. A large study found that cows with a
BCS of 3 at insemination are most likely to become pregnant (Loeffler et al., 1999). The
information indicating that negative energy balance and BCS at the time of insemination
are related to reproductive performance agrees on some levels with the data presented in
this study. Overall there was no statistical difference detected in pregnancy rates with
respect to BCS, but cows with a BCS of 3.5 were numerically higher at 62.5% compared
to 44.44, 30.0, and 36.84% for BCS of 2, 2.5, and 3. These results agree with the
indication that cows must be in a sound state of energy balance and BCS in order to
perform well reproductively. However, these results disagree with Loeffler et al. (1999)
that a BCS of 3 result in the highest pregnancy rates.
Results of this study also indicated that rBST along with BCS had a tendency to
affect pregnancy rates. The fact that rBST had a tendency to lower pregnancy rates for
cows with a BCS of 3 is puzzling considering no effect was detected for rBST
administered cows at a BCS of 2. The information from previous investigators indicates
that rBST may decrease reproductive performance (Cole et al., 1991; Cole et al., 1992;
reviewed by Dohoo et al., 2003).

A low body condition score of 2 along with

administration of rBST should decrease reproductive performance. However, the animals
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with the ideal BCS of 3 were experiencing the greatest loss of reproductive function
when administered rBST.

Perhaps an animal must be in a state of adequate body

condition before a difference can be noticed.
In conclusion administration of FM on day 5 following artificial insemination did
not result in increased pregnancy rates.

This finding may be due to timing of

administration, route of administration, absence of an adequate stressor, or the limited
number of animals utilized. More research is needed to address the timing and route of
administration of FM following artificial insemination. Also, no significant effect on
pregnancy rates were detected with respect to breed, DIM, BCS, MP or 305ME.
However, pregnancy rates had a tendency to decrease for cows in LN 3+ compared to LN
1. Recombinant bST was found to decrease pregnancy rates of lactating dairy cattle
regardless of treatment.

The greatest decrease in pregnancy rates was detected for

animals < 100 DIM and administered rBST. More research is needed to maximize
efficiency of FM as a PGF2α inhibitor during artificial insemination, and development of
management practices to minimize the detrimental effects of rBST on reproductive
performance during early lactation.
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